Join the 155,000+ IMP followers

Fraunhofer News

FRAUNHOFER: DESIGNER IMMUNE CELLS FOR DRUG DISCOVERY, POTENCY AND SAFETY TESTING

To prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells. However, the availability of cells like these has been limited to date. Now, Fraunhofer researchers have succeeded in scaling the production of customized immune cells from laboratory up to industrial level.

Intel News

Helping Shape the Future of Healthcare with Technology

Patients can soon use smartphones to watch properly executed physical therapy exercises via volumetric 3D immersive videos powered by Intel processors.

Sysgo News

SYSGO: PikeOS achieves Common Criteria (CC) level EAL5+ Security Certification

SYSGO has responded to the increased cybersecurity threat level: Separation Kernel PikeOS 5.1.3. has attained the most widely accepted security certification standard Common Criteria (CC), also known as ISO 15408, at level EAL 5+ for the leading application processor architectures ARMv8, x86-64 and PPC.

Carel News

A new CAREL white paper on the challenges involving the cold chain in scientific applications

CAREL has published a new white paper entitled “The importance of temperature in pharmaceutical storage and the challenges for the cold chain”, which analyses the various factors that impact the correct storage of medicines and the need to adopt control and monitoring solutions in scientific applications.

GEA GROUP News

HOVIONE AND GEA ANNOUNCE A STRATEGIC COLLABORATION TO ADVANCE CONTINUOUS TABLETING

Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA’s engineering expertise with Hovione’s development and manufacturing experience and both parties commit to partner to accelerate the adoption of Continuous Tableting technology.

Fraunhofer News

AI enables greater mobility: Personalized finger joint implants from a 3D printer

The remobilization of finger joints that have been damaged by illness or injury is an emerging market in the field of demand-driven patient care. The FingerKIt consortium, which brings together five Fraunhofer institutes, uses AI to develop personalized 3D-printed joint implants so that these delicate finger parts can be replaced when necessary.

Join the 155,000+ IMP followers

International